Reviva Pharmaceuticals Holdings (RVPH) Records 37% Gain So far in 2026
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) is one of the stocks under $1 that will explode. Reviva Pharmaceuticals Holdings (RVPH) Records…
Tag: Pharmaceuticals
Alnylam Pharmaceuticals CEO on Development Goals, Profitability
Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses the company’s development goals and being on the verge of profitability during an interview…
Tern Pharmaceuticals (TERN) Soars 630% on CML Treatment Best-in-Class Potential
We recently published 10 Market Stars Behind Millionaire-Making in 2025. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the top performers.…
Vanda Pharmaceuticals price target raised to $14 from $11 at B. Riley
B. Riley raised the firm’s price target on Vanda Pharmaceuticals (VNDA) to $14 from $11 and keeps a Buy rating…
Vertex Pharmaceuticals price target raised to $525 from $456 at Leerink
Leerink raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $525 from $456 and keeps an Outperform rating on…
Here’s Why Shares in Agios Pharmaceuticals Popped Today
The new indication is relatively rare in the U.S., but pricing is substantial, and the need for the treatment is…
Why Analysts Favor Kiniksa Pharmaceuticals (KNSA)
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) is one of the most promising mid-cap healthcare stocks under $50. On December 12, Wells Fargo…
US and UK agree zero tariffs deal on pharmaceuticals
The UK and the US have agreed a deal to keep tariffs on UK pharmaceutical imports into the America at…
China Holds All the Cards in Global Pharmaceuticals
The US and China may have called a truce on trade, but Beijing has other levers to pull should febrile relations deteriorate again. That’s a…
What To Expect From Vertex Pharmaceuticals’ Report
With a market cap of $104.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company focused on discovering, developing, and commercializing…